Patent Yard Sign in
Canadian application, no grantCanada

Fibrinolytic inhibitor for sealant

CA 2313405 A1 · Owner: Cederholm-Williams, Stewart A. · Inventors: Cederholm-Williams, Stewart A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides a kit for preparing a fibrin sealant either (A) comprising: (a) a fibrin monomer preparation; (b) a stabilizing preparation containing a clot-preserving effective amount of a fibrinolysis-inhibiting protein; and (c) a non-enzymatic polymerizing agent preparation effective to convert the fibrin monomer preparation into a fibrin clot; or (B) comprising: (a') a fibrin monomer preparation comprising a fibrin monomer and a clotpreserving effective amount of a fibrinolysis-inhibiting protein; and (c') a polymerizing agent preparation effective to convert the fibrin monomer preparation into a fibrin clot.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 9, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 9, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 9, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 9, 1998
GrantedNo grant recorded
Term endedDecember 9, 2018
Patent numberCA 2313405 A1
Classification (IPC)A61K38/36 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedDec 9, 1998Term endedDec 9, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.